LEVAMLODIPINE

LEVAMLODIPINE was reported 125 times

LEVAMLODIPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 METASTASES TO THYROID 1 0.0109
1 LABELLED DRUG-DISEASE INTERACTION ISSUE 1 0.0105
2 DUODENAL NEOPLASM 1 0.0102
3 PLEURAL CALCIFICATION 1 0.0087
4 SUPERIOR VENA CAVA OCCLUSION 1 0.0079
5 BLOOD GASTRIN INCREASED 1 0.0078
6 CONJUNCTIVAL PALLOR 1 0.0055
7 VERTEBROBASILAR INSUFFICIENCY 1 0.0055
8 COR PULMONALE CHRONIC 1 0.0053
9 PLEURAL ADHESION 1 0.0050
10 PULMONARY CALCIFICATION 2 0.0048
11 VESSEL PUNCTURE SITE HAEMORRHAGE 1 0.0041
12 GINGIVAL ULCERATION 2 0.0027
13 CRYSTAL URINE PRESENT 1 0.0018
14 BLOOD VISCOSITY INCREASED 1 0.0017
15 INJECTION SITE EXFOLIATION 1 0.0015
16 PLEURAL THICKENING 1 0.0015
17 NODAL RHYTHM 2 0.0014
18 BLISTER RUPTURE 1 0.0013
19 MICROALBUMINURIA 1 0.0013
20 CREATINE KINASE INCREASED 1 0.0013
21 ENDOCARDITIS BACTERIAL 1 0.0013
22 SOLILOQUY 1 0.0012
23 PSEUDOMONAL SEPSIS 2 0.0011
24 RED BLOOD CELLS URINE POSITIVE 1 0.0010
25 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
26 CAROTID ARTERIOSCLEROSIS 1 0.0010
27 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
28 DEMENTIA WITH LEWY BODIES 1 0.0009
29 CEREBRAL ARTERY EMBOLISM 1 0.0008
30 CORNEAL ABRASION 1 0.0007
31 LOW DENSITY LIPOPROTEIN DECREASED 1 0.0007
32 CHORIORETINOPATHY 1 0.0007
33 GINGIVAL HYPERTROPHY 1 0.0007
34 CALCULUS URINARY 1 0.0006
35 DAYDREAMING 1 0.0006
36 GASTROINTESTINAL INFLAMMATION 5 0.0006
37 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
38 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
39 BURNS SECOND DEGREE 1 0.0006
40 IMMUNE-MEDIATED LUNG DISEASE 1 0.0005
41 DISORGANISED SPEECH 1 0.0005
42 ATROPHY 1 0.0005
43 APLASIA 1 0.0005
44 UNDERWEIGHT 1 0.0005
45 RENAL MASS 1 0.0005
46 ABSCESS LIMB 2 0.0005
47 POLYP 3 0.0005
48 CARDIAC FAILURE ACUTE 3 0.0004
49 RHINITIS ALLERGIC 2 0.0004
50 GASTROINTESTINAL OBSTRUCTION 1 0.0004
51 STARING 1 0.0004
52 CANCER PAIN 1 0.0004
53 INCREASED BRONCHIAL SECRETION 1 0.0004
54 AORTIC ARTERIOSCLEROSIS 1 0.0004
55 HEPATITIS TOXIC 1 0.0004
56 LUNG OPACITY 1 0.0004
57 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
58 HYPERLACTACIDAEMIA 1 0.0004
59 GASTRIC PERFORATION 1 0.0004
60 PSEUDOMONAS INFECTION 3 0.0003
61 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
62 URINE ANALYSIS ABNORMAL 1 0.0003
63 PIGMENTATION DISORDER 2 0.0003
64 ABDOMINAL ADHESIONS 1 0.0003
65 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
66 LOGORRHOEA 1 0.0003
67 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
68 APPARENT DEATH 1 0.0003
69 SPONDYLITIS 1 0.0003
70 THROMBOCYTOSIS 1 0.0003
71 PROCEDURAL COMPLICATION 2 0.0003
72 RHINITIS 2 0.0002
73 HYPERURICAEMIA 1 0.0002
74 SKIN PLAQUE 2 0.0002
75 CARDIAC FAILURE CHRONIC 1 0.0002
76 OCULAR ICTERUS 1 0.0002
77 ABDOMINAL HERNIA 1 0.0002
78 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
79 SPINAL DISORDER 2 0.0002
80 FAECAL INCONTINENCE 1 0.0002
81 ERYSIPELAS 1 0.0002
82 NEUTROPHIL COUNT INCREASED 2 0.0002
83 CEREBRAL ISCHAEMIA 1 0.0002
84 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
85 TOOTH DISORDER 4 0.0002
86 BLOOD UREA INCREASED 3 0.0002
87 INTESTINAL PERFORATION 2 0.0002
88 PERIORBITAL SWELLING 1 0.0002
89 CHOLECYSTITIS ACUTE 1 0.0002
90 SPINAL PAIN 2 0.0002
91 COLD SWEAT 3 0.0002
92 CATARACT OPERATION 1 0.0002
93 HYPERLIPIDAEMIA 2 0.0002
94 MUSCLE RIGIDITY 2 0.0002
95 HEARING IMPAIRED 1 0.0002
96 GANGRENE 1 0.0002
97 SCOLIOSIS 1 0.0002
98 SECRETION DISCHARGE 2 0.0002
99 ANGINA UNSTABLE 1 0.0002
100 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
101 BONE MARROW FAILURE 3 0.0001
102 JOINT EFFUSION 1 0.0001
103 AUTOIMMUNE HEPATITIS 1 0.0001
104 EXTRASYSTOLES 1 0.0001
105 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
106 THERMAL BURN 1 0.0001
107 PRODUCT SUPPLY ISSUE 1 0.0001
108 PSYCHIATRIC SYMPTOM 1 0.0001
109 ACIDOSIS 1 0.0001
110 DRUG-INDUCED LIVER INJURY 4 0.0001
111 AFFECTIVE DISORDER 1 0.0001
112 ACUTE CORONARY SYNDROME 1 0.0001
113 MYOPATHY 1 0.0001
114 BLOOD CALCIUM INCREASED 1 0.0001
115 JAUNDICE 3 0.0001
116 NERVE COMPRESSION 1 0.0001
117 HYPOKALAEMIA 5 0.0001
118 HEPATIC STEATOSIS 2 0.0001
119 ERYTHEMA MULTIFORME 1 0.0001
120 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
121 HOSPICE CARE 1 0.0001
122 SUBARACHNOID HAEMORRHAGE 1 0.0001
123 SLUGGISHNESS 1 0.0001
124 EUPHORIC MOOD 1 0.0001
125 NERVOUS SYSTEM DISORDER 3 0.0001
126 BODY HEIGHT DECREASED 1 0.0001
127 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
128 GASTROINTESTINAL PAIN 1 0.0001
129 GASTRIC HAEMORRHAGE 1 0.0001
130 COVID-19 PNEUMONIA 1 0.0001
131 CHOLECYSTITIS 1 0.0001
132 CEREBRAL INFARCTION 2 0.0001
133 UNRESPONSIVE TO STIMULI 2 0.0001
134 HAEMATOMA 2 0.0001
135 INJECTION SITE INDURATION 1 0.0001
136 NODULE 1 0.0001
137 INCORRECT PRODUCT STORAGE 1 0.0001
138 BEDRIDDEN 1 0.0001
139 BLOOD PRESSURE DECREASED 5 0.0001
140 TACHYPNOEA 1 0.0001
141 PERIPHERAL COLDNESS 1 0.0001
142 BLOOD TEST ABNORMAL 1 0.0001
143 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
144 HYPOKINESIA 1 0.0001
145 ACUTE MYOCARDIAL INFARCTION 2 0.0001
146 CATARACT 4 0.0001
147 HAEMORRHAGE INTRACRANIAL 1 0.0001
148 CORONARY ARTERY DISEASE 2 0.0001
149 STOMATITIS 4 0.0001
150 LIMB DISCOMFORT 2 0.0001
151 ACUTE MYELOID LEUKAEMIA 1 0.0001
152 DRUG LEVEL INCREASED 1 0.0001
153 COAGULOPATHY 1 0.0001
154 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
155 DELIRIUM 2 0.0001
156 LOCAL SWELLING 1 0.0001
157 DEPRESSED MOOD 3 0.0001
158 GOUT 1 0.0001
159 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
160 HYPERGLYCAEMIA 2 0.0001
161 BONE DISORDER 1 0.0001
162 BLOOD GLUCOSE ABNORMAL 1 0.0001
163 CONJUNCTIVITIS 1 0.0001
164 NECK PAIN 3 0.0001
165 HEPATIC FUNCTION ABNORMAL 2 0.0001
166 HEPATIC CIRRHOSIS 1 0.0001
167 PROTEINURIA 1 0.0001
168 PULMONARY FIBROSIS 1 0.0001
169 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
170 ABNORMAL BEHAVIOUR 2 0.0001
171 UPPER LIMB FRACTURE 1 0.0001
172 SPINAL FRACTURE 1 0.0000
173 CARDIO-RESPIRATORY ARREST 2 0.0000
174 MOUTH ULCERATION 1 0.0000
175 SKIN EXFOLIATION 4 0.0000
176 EATING DISORDER 1 0.0000
177 HYPOAESTHESIA 7 0.0000
178 LIVER FUNCTION TEST INCREASED 1 0.0000
179 FAECES DISCOLOURED 1 0.0000
180 MELAENA 1 0.0000
181 APPLICATION SITE PAIN 1 0.0000
182 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
183 RASH MACULO-PAPULAR 1 0.0000
184 PANCREATITIS ACUTE 1 0.0000
185 CHROMATURIA 1 0.0000
186 PRODUCT AVAILABILITY ISSUE 1 0.0000
187 SHOCK 1 0.0000
188 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
189 ARRHYTHMIA 2 0.0000
190 BLOOD PRESSURE FLUCTUATION 1 0.0000
191 HYPOGLYCAEMIA 2 0.0000
192 PRESYNCOPE 1 0.0000
193 LUNG DISORDER 2 0.0000
194 LIVER INJURY 1 0.0000
195 EXTRAPYRAMIDAL DISORDER 1 0.0000
196 PRODUCT COMPLAINT 1 0.0000
197 ANAPHYLACTIC SHOCK 1 0.0000
198 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
199 SPEECH DISORDER 2 0.0000
200 HYPERTENSION 8 0.0000
201 PLATELET COUNT DECREASED 4 0.0000
202 CARDIAC FAILURE 3 0.0000
203 OEDEMA 2 0.0000
204 PNEUMONITIS 1 0.0000
205 DEMENTIA 1 0.0000
206 RENAL IMPAIRMENT 3 0.0000
207 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
208 FLATULENCE 2 0.0000
209 MUSCULAR WEAKNESS 4 0.0000
210 NEEDLE ISSUE 1 0.0000
211 DYSSTASIA 1 0.0000
212 DYSPHONIA 2 0.0000
213 NASAL CONGESTION 2 0.0000
214 DISEASE PROGRESSION 4 0.0000
215 URINARY INCONTINENCE 1 0.0000
216 BLOOD POTASSIUM DECREASED 1 0.0000
217 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
218 SUICIDE ATTEMPT 2 0.0000
219 OEDEMA PERIPHERAL 4 0.0000
220 VERTIGO 2 0.0000
221 FEELING HOT 2 0.0000
222 BONE DENSITY DECREASED 1 0.0000
223 HYPOTHYROIDISM 1 0.0000
224 BLOOD CREATININE INCREASED 2 0.0000
225 INFUSION RELATED REACTION 2 0.0000
226 EXPIRED PRODUCT ADMINISTERED 1 0.0000
227 INJECTION SITE PRURITUS 2 0.0000
228 TYPE 2 DIABETES MELLITUS 1 0.0000
229 HAEMATURIA 1 0.0000
230 NEOPLASM PROGRESSION 1 0.0000
231 ABDOMINAL DISTENSION 3 0.0000
232 RASH MACULAR 1 0.0000
233 HYPOXIA 1 0.0000
234 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
235 CEREBRAL HAEMORRHAGE 1 0.0000
236 CONSTIPATION 6 0.0000
237 ACCIDENTAL OVERDOSE 1 0.0000
238 RESTLESSNESS 1 0.0000
239 INFLUENZA 3 0.0000
240 DYSPNOEA EXERTIONAL 1 0.0000
241 ASTHMA 3 0.0000
242 HALLUCINATION 2 0.0000
243 COLITIS 1 0.0000
244 ANAEMIA 5 0.0000
245 BLOOD PRESSURE INCREASED 4 0.0000
246 GAIT DISTURBANCE 5 0.0000
247 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
248 DECREASED APPETITE 6 0.0000
249 PALPITATIONS 3 0.0000
250 ARTHRITIS 2 0.0000
251 OSTEOPOROSIS 1 0.0000
252 CARDIAC ARREST 2 0.0000
253 RHABDOMYOLYSIS 1 0.0000
254 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
255 HYPOACUSIS 1 0.0000
256 MENTAL DISORDER 1 0.0000
257 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
258 SKIN DISCOLOURATION 1 0.0000
259 PNEUMONIA 7 0.0000
260 WEIGHT DECREASED 6 0.0000
261 BLOOD CHOLESTEROL INCREASED 1 0.0000
262 COMA 1 0.0000
263 BLOOD GLUCOSE DECREASED 1 0.0000
264 CONTUSION 2 0.0000
265 ATRIAL FIBRILLATION 2 0.0000
266 PAIN IN EXTREMITY 6 0.0000
267 DYSPEPSIA 2 0.0000
268 SYNCOPE 2 0.0000
269 AGGRESSION 1 0.0000
270 FLUSHING 2 0.0000
271 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
272 DRUG INTERACTION 3 0.0000
273 DIARRHOEA 12 0.0000
274 HAEMATOCHEZIA 1 0.0000
275 ARTHROPATHY 1 0.0000
276 COUGH 5 0.0000
277 BLISTER 1 0.0000
278 OXYGEN SATURATION DECREASED 1 0.0000
279 TOXICITY TO VARIOUS AGENTS 3 0.0000
280 DEPRESSION 4 0.0000
281 BACK PAIN 4 0.0000
282 ABDOMINAL PAIN 4 0.0000
283 BONE PAIN 1 0.0000
284 CHILLS 2 0.0000
285 ARTHRALGIA 7 0.0000
286 PLEURAL EFFUSION 1 0.0000
287 DISCOMFORT 1 0.0000
288 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
289 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
290 INJECTION SITE ERYTHEMA 2 0.0000
291 PRODUCT USE ISSUE 3 0.0000
292 MALAISE 7 0.0000
293 HYPERHIDROSIS 2 0.0000
294 AMNESIA 1 0.0000
295 PSORIASIS 2 0.0000
296 RENAL FAILURE 2 0.0000
297 DRY SKIN 2 0.0000
298 VISION BLURRED 2 0.0000
299 INJECTION SITE REACTION 1 0.0000
300 PYREXIA 5 0.0000
301 UNDERDOSE 1 0.0000
302 AGITATION 1 0.0000
303 WEIGHT INCREASED 3 0.0000
304 EPISTAXIS 1 0.0000
305 HOT FLUSH 1 0.0000
306 CHRONIC KIDNEY DISEASE 1 0.0000
307 DIABETES MELLITUS 1 0.0000
308 PAIN 8 0.0000
309 HOSPITALISATION 2 0.0000
310 PERIPHERAL SWELLING 2 0.0000
311 VOMITING 6 0.0000
312 PARAESTHESIA 2 0.0000
313 DRY MOUTH 1 0.0000
314 INFLUENZA LIKE ILLNESS 1 0.0000
315 TREMOR 2 0.0000
316 INSOMNIA 3 0.0000
317 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
318 SUICIDAL IDEATION 1 0.0000
319 CARDIAC DISORDER 1 0.0000
320 ASTHENIA 4 0.0000
321 BLOOD GLUCOSE INCREASED 2 0.0000
322 DYSPNOEA 6 0.0000
323 ANXIETY 3 0.0000
324 DRUG INTOLERANCE 1 0.0000
325 FATIGUE 8 0.0000
326 NAUSEA 8 0.0000
327 HEART RATE INCREASED 1 0.0000
328 SOMNOLENCE 2 0.0000
329 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
330 CHEST DISCOMFORT 1 0.0000
331 HAEMOGLOBIN DECREASED 1 0.0000
332 ILLNESS 1 0.0000
333 HAEMORRHAGE 1 0.0000
334 OVERDOSE 2 0.0000
335 SEPSIS 1 0.0000
336 THROMBOCYTOPENIA 1 0.0000
337 JOINT SWELLING 1 0.0000
338 VISUAL IMPAIRMENT 1 0.0000
339 DIZZINESS 4 0.0000
340 LOSS OF CONSCIOUSNESS 1 0.0000
341 MEMORY IMPAIRMENT 1 0.0000
342 INFECTION 1 0.0000
343 OFF LABEL USE 6 0.0000
344 ACUTE KIDNEY INJURY 1 0.0000
345 INJECTION SITE PAIN 2 0.0000
346 HEADACHE 4 0.0000
347 DRUG DEPENDENCE 1 0.0000
348 CONFUSIONAL STATE 1 0.0000
349 FALL 2 0.0000
350 ABDOMINAL DISCOMFORT 1 0.0000
351 CEREBROVASCULAR ACCIDENT 1 0.0000
352 MYALGIA 1 0.0000
353 URINARY TRACT INFECTION 1 0.0000
354 MYOCARDIAL INFARCTION 1 0.0000
355 HYPERSENSITIVITY 1 0.0000
356 DRUG INEFFECTIVE 7 0.0000
357 PRURITUS 2 0.0000
358 ALOPECIA 1 0.0000
359 ERYTHEMA 1 0.0000
360 RASH 2 0.0000
361 INCORRECT DOSE ADMINISTERED 1 0.0000
362 FEELING ABNORMAL 1 0.0000
363 PRODUCT DOSE OMISSION ISSUE 1 0.0000
364 CONDITION AGGRAVATED 1 0.0000